Skip to main content
. Author manuscript; available in PMC: 2013 Sep 12.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2008 Jan 9;17(1):148–157. doi: 10.1158/1055-9965.EPI-07-0517

Table 1.

Characteristics of participants

Variable Cases, n (%) Controls, n (%) P
n 581 541
Age (y) 60.0 (9.3) 59.0 (9.4) 0.07
Race
 African American 136 (23.4) 131 (24.2) 0.75
 Caucasian 445 (76.6) 410 (75.8)
Smoking status
 Never 56 (9.7) 268 (49.9) <0.0001
 Former 191 (32.9) 168 (31.3)
 Current 333 (57.4) 101 (18.8)
Pack-years among smokers 46.5 (29.3) 24.5 (22.6) <0.0001
Smoking history level
 Never 56 (9.7) 268 (50.0) <0.0001
 1–20 Pack-years 90 (15.5) 146 (27.2)
 >20 Pack-years 433 (74.8) 122 (22.8)
Education
 <12 y 108 (18.6) 46 (8.5) <0.0001
 High school or GED 239 (41.2) 166 (30.7)
 Beyond high school 233 (40.2) 329 (60.8)
History of COLD
 No 398 (68.5) 464 (85.8) <0.0001
 Yes 183 (31.5) 77 (14.2)
Family history of lung cancer
 No 431 (74.3) 478 (88.4) <0.0001
 Yes 149 (25.7) 63 (11.6)
Current BMI (kg/m2) 26.2 (5.9) 29.5 (7.3) <0.0001
Pill use
 Baby aspirin 89 120
 Adult aspirin 129 132
 Acetaminophen 126 104
 NSAID 124 149
Years of use (among pill users)*
 Baby aspirin 3.8 (3.5) 3.5 (3.5) 0.52
 Adult aspirin 9.1 (9.7) 8.7 (9.9) 0.79
 Acetaminophen 7.7 (9.4) 7.5 (8.6) 0.88
 NSAID 5.9 (7.1) 4.7 (6.0) 0.15
*

Outliers (>3 SD from the mean) were excluded from this analysis.